摘要
[目的]观察艾迪注射液联合化疗治疗晚期卵巢癌的临床疗效。[方法]将60例晚期卵巢癌患者随机分为治疗组30例和对照组30例,对照组接受单纯化疗,治疗组在化疗基础上用艾迪注射液治疗,21d为1个周期,2个周期后比较两组的临床疗效。[结果]艾迪注射液具有增加化疗疗效,提高化疗患者生存质量及增加患者体重等作用,与对照组有显著性差异(P<0.05)。[结论]艾迪注射液联合化疗在晚期卵巢癌治疗中有较好疗效,值得临床进一步推广使用。
[ Objective] To observe the therapeutic effet of Aidi injection combined with chemotherapy in treatment of advanced ovarian cancer. [ Methods ] 60 patients with advanced ovarian cancer were randomly di- vided into two groups. The control group was treated with conventional chemotherapy, and the treatment group was treated with Aidi injection and chemotherapy,21 days as one cycle, and the therapeutic effet was evalua- ted after 2 cycles. [ Results ] The Aidi injection increased the efficacy of chemotherapy, improved the quality of life and weight in patients with advanced ovarian cancer. The difference was significant （ P 〈0. 05 ） compared with the control group. [ Conclusion] A higher response rate was attainable in patients with advanced ovarian cancer by Aidi injection combined with chemotherapy.
出处
《实用中医内科杂志》
2012年第6期5-5,8,共2页
Journal of Practical Traditional Chinese Internal Medicine
关键词
晚期卵巢癌
艾迪注射液
化疗
中西医治疗
Advanced ovarian cancer
Aidi injection
Chemotherapy
Combine Chinese and Western medicine treatment
